# cleviprex.com

> CLEVIPREX® (clevidipine) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure (BP) when oral therapy is not feasible or not desirable. See full Prescribing and Safety Information.

## Key Pages
- [Home](https://cleviprex.com/): Overview and main navigation.
- [Important Safety Information](https://cleviprex.com/#isi): Safety profile and usage warnings.
- [Efficacy](https://cleviprex.com/efficacy/): Efficacy and clinical trial information.
- [Safety](https://cleviprex.com/safety/): Safety information from the ECLIPSE clinical study. 
- [Pharmacology & MOA](https://cleviprex.com/pharmacology-moa/): Pharmacology, pharmacokinetic and mechanism of action information. 
- [Dosing](https://cleviprex.com/dosing-administration/): Dosing and administration guidance. 
- [Contact](https://cleviprex.com/request-information/): Get in touch with our team.

## Resources
- [HCP Resources](https://cleviprex.com/resources/): Health care provider resources for care teams. 
- [FAQs](https://cleviprex.com/resources/faqs/): Frequently asked questions.
- [AHA/ASA AIS Guidelines](https://cleviprex.com/resources/ais-guidelines/): 2018 AHA/ASA AIS Guidelines.
- [AHA/ASA ICH Guidelines] (https://cleviprex.com/resources/ich-guidelines/): 2022 AHA/ASA ICH Guidelines. 
- [Terms of Use](https://cleviprex.com/terms): Legal terms and conditions.
- [Privacy Policy](https://cleviprex.com/privacy): Data collection and privacy policy.

## Additional
- [Dosing & Administration Guide PDF](https://cleviprex.com/wp-content/uploads/CLEVIPREX_Dosing_and_Administration_Fact_Sheet.pdf): Downloadable dosing summary for Cleviprex.
- [2018 AHA/ASA AIS Guidelines PDF](https://cleviprex.com/wp-content/uploads/cleviprex_ais_guidelines.pdf): Downloadable summary of the 2018 AHA/ASA AIS Guidelines with information on CLEVIPREX.